| Designing drugs that overcome antibacterial resistance: where do we stand and what should we do? R Penchovsky, M Traykovska Expert opinion on drug discovery 10 (6), 631-650, 2015 | 97 | 2015 |
| Engineering antisense oligonucleotides as antibacterial agents that target FMN riboswitches and inhibit the growth of Staphylococcus aureus, Listeria monocytogenes, and … M Traykovska, R Penchovsky ACS Synthetic Biology 11 (5), 1845-1855, 2022 | 26 | 2022 |
| Targeting glmS ribozyme with chimeric antisense oligonucleotides for antibacterial drug development M Traykovska, KB Popova, R Penchovsky ACS Synthetic Biology 10 (11), 3167-3176, 2021 | 23 | 2021 |
| Targeting TPP riboswitches using chimeric antisense oligonucleotide technology for antibacterial drug development M Traykovska, LA Otcheva, R Penchovsky ACS Applied Bio Materials 5 (10), 4896-4902, 2022 | 16 | 2022 |
| Targeting SAM-I Riboswitch Using Antisense Oligonucleotide Technology for Inhibiting the Growth of Staphylococcus aureus and Listeria monocytogenes M Traykovska, R Penchovsky Antibiotics 11 (11), 1662, 2022 | 14 | 2022 |
| Mechanisms of antibacterial drug resistance and approaches to overcome A Valsamatzi-Panagiotou, M Traykovska, R Penchovsky Drug Discovery Targeting Drug-Resistant Bacteria, 9-37, 2020 | 6 | 2020 |
| Clinical trials of functional nucleic acids: antisense oligonucleotides and aptamers M Traykovska, S Miedema, R Penchovsky International Journal of Biomedical and Clinical Engineering (IJBCE) 7 (2 …, 2018 | 6 | 2018 |
| Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development N Pavlova, M Traykovska, R Penchovsky Antibiotics 12 (11), 1607, 2023 | 5 | 2023 |
| Versatile tools of synthetic biology applied to drug discovery and production N Pavlova, GY Miloshev, AV Georgieva, M Traykovska, R Penchovsky Future Medicinal Chemistry 14 (18), 1325-1340, 2022 | 5 | 2022 |
| Antisense and Functional Nucleic Acids in Rational Drug Development R Penchovsky, AV Georgieva, V Dyakova, M Traykovska, N Pavlova Antibiotics 13 (3), 221, 2024 | 4 | 2024 |
| Small RNA-based systems for sensing and therapeutic applications R Penchovsky, GY Miloshev, N Pavlova, KB Popova, ... New Frontiers and Applications of Synthetic Biology, 103-121, 2022 | 3 | 2022 |
| RNA as a potent target for antibacterial drug discovery KB Popova, LA Otcheva, M Traykovska, R Penchovsky Biomedical Journal of Scientific & Technical Research 10 (2), 7752-7754, 2018 | 2 | 2018 |
| Synthetic Approaches to Biology: Engineering Gene Control Circuits, Synthesizing, and Editing Genomes R Penchovsky, M Traykovska Emerging Research on Bioinspired Materials Engineering, 323-351, 2016 | 1 | 2016 |
| Various therapies against SARS-CoV-2 A Valsamatzi-Panagiotou, M Traykovska, GY Miloshev, R Penchovsky | | 2023 |
| Engineering a Plasmid as a Reporter System for Quantifying Gene Expression in Escherichia Coli GY Miloshev, M Traykovska, D Kaloudas, R Penchovsky Proceedings of the Bulgarian Academy of Sciences 75 (1), 56-61, 2022 | | 2022 |
| Coronavirus SARS-CoV-2: Where do we stand? A Valsamatzi-Panagiotou, M Traykovska, R Penchovsky | | 2022 |
